Simvastatin Cinfa: Why Health has withdrawn a batch of this drug for cholesterol

2022-07-24 00:22:29 By : Mr. Harry Wang

and enjoy the advantages of being a subscriberThe Spanish Agency for Medicines and Health Products (AEMPS), dependent on the Ministry of Health, has ordered the withdrawal of a batch of the statin Simvastatin Cinfa 40 mg film-coated tablets EFG for having an "unauthorized version of packages and prospectuses".Specifically, the batch affected is BT1432, with an expiration date of June 30, 2023, from the Cinfa laboratory.Faced with this situation, the AEMPS has ordered the "withdrawal from the market of all the distributed units of the affected batches and their return to the laboratory through the usual channels".This drug contains the active ingredient simvastatin, which is used to lower levels of total cholesterol, "bad" cholesterol (LDL cholesterol), and fatty substances called triglycerides that circulate in the blood.In addition, it raises the concentrations of "good" cholesterol (HDL cholesterol).Who we are Contact RSS Site map Advertising Legal notice Privacy and cookies policy Privacy PreferencesOther websites of Prensa Ibérica Media:Buscandorespuestas.com Cartoon Network Used Car BuyBest Cuore Diario Córdoba Diari de Girona Diario de Mallorca Diario de Ibiza El Día Tenerife Sport The Newspaper of Aragón The Newspaper of Catalonia The Newspaper of Spain The Newspaper Extremadura The Newspaper Mediterráneo Faro de Vigo Neomotor Formula1 Beautiful Iberempleos Information Information TV The Chronicle of Badajoz The New Spain The Opinion of A Coruña The Opinion of Malaga The Opinion of Murcia The Opinion The Mail of Zamora La Provincia Diario de Las Palmas Levante El Mercantil Valenciano Levante TV Empordà Christmas Lottery Mallorca Zeitung Neox Kidz Goya Awards Awards Oscar Regió7 Stilo Superdeporte Environment Trends21 Tucasa Travel Woman Cambalache Iberpisos